PropertyValue
?:abstract
  • Viral papain-like cysteine protease (PLpro, NSP3) is essential for SARS-CoV-2 replication and represents a promising target for the development of antiviral drugs. Here, we used a combinatorial substrate library and performed comprehensive activity profiling of SARS-CoV-2 PLpro. On the scaffold of the best hits from positional scanning, we designed optimal fluorogenic substrates and irreversible inhibitors with a high degree of selectivity for SARS PLpro. We determined crystal structures of two of these inhibitors in complex with SARS-CoV-2 PLpro that reveals their inhibitory mechanisms and provides a molecular basis for the observed substrate specificity profiles. Last, we demonstrate that SARS-CoV-2 PLpro harbors deISGylating activity similar to SARSCoV-1 PLpro but its ability to hydrolyze K48-linked Ub chains is diminished, which our sequence and structure analysis provides a basis for. Together, this work has revealed the molecular rules governing PLpro substrate specificity and provides a framework for development of inhibitors with potential therapeutic value or drug repurposing.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1126/sciadv.abd4596
?:journal
  • Sci_Adv
?:license
  • cc-by-nc
?:pdf_json_files
  • document_parses/pdf_json/7db07afaeb564c626fa4d27ad23024d37de4397b.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7567588.xml.json
?:pmcid
?:pmid
?:pmid
  • 33067239.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design
?:type
?:year
  • 2020-10-16

Metadata

Anon_0  
expand all